ACTIVE

Conrad Pharma

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result199,2 k €+5,6 %over 1 year
Gross margin504,8 k €+17,4 %over 1 year
Equity1,1 M €-4,3 %over 1 year
Workforce2,5 ETP+8,7 %over 1 year

Identity

Source · BCE/KBO

Conrad Pharma is a Private limited company incorporated in 2013. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Oudenaarde. It employs on average 2,5 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0536.875.697
Incorporation
23/07/2013
Legal form
Private limited company
Registered office
Diependale 8
9700 Oudenaarde · FlandreSee on map
Contributed capital
100 000,00 €
Latest accounts
31/12/2025
Average workforce
2,5 ETP
Joint committees (1)
  • 313
Signals
ProfitablePositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 12 filings

Trend over 12 financial years

20252024202320222021
Income statement
Gross margin504,8 k €430 k €450,3 k €474,2 k €466,3 k €
EBITDA368,5 k €276,4 k €308,6 k €376,1 k €356,2 k €
Operating result293,8 k €203,7 k €240,9 k €314,5 k €296,3 k €
Net result199,2 k €188,6 k €192,3 k €295,5 k €189,4 k €
Balance sheet
Equity1,1 M €1,2 M €1,1 M €896 k €600,5 k €
Total assets5 M €5,7 M €3,5 M €3,5 M €3,4 M €
Cash185,9 k €104,7 k €166,1 k €94,8 k €59,1 k €
Debts3,8 M €4,4 M €2,4 M €2,5 M €2,8 M €
Other
Workforce2,5 ETP2,3 ETP2,8 ETP1,9 ETP2,3 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Philippe Verzele
DirectorManager2018 accountsended
Vanessa Pluym
DirectorManager2018 accountsended

Other companies at this address

Diependale 8 9700 Oudenaarde
CompanyCBE no.
DECAPHAR● Active
0843.302.261
GEVA PHARMA● Active
0427.597.576
VERZELE PHARMA● Active
0896.764.703
VERZELE PHARMA ZWALM● Active
0475.231.407

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date28/08/202629/08/202512/07/202405/07/202325/08/202216/09/2021
General meeting24/08/202627/08/202520/06/202415/06/202316/08/202219/08/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 12 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202524/08/202628/08/2026DutchPDF
Abridged model31/12/202427/08/202529/08/2025DutchPDF
Abridged model31/12/202320/06/202412/07/2024DutchPDF
Abridged model31/12/202215/06/202305/07/2023DutchPDF
Abridged model31/12/202116/08/202225/08/2022DutchPDF
Abridged model31/12/202019/08/202116/09/2021DutchPDF
Abridged model31/12/201927/08/202014/09/2020DutchPDF
Abridged model31/12/201829/08/201923/09/2019DutchPDF
Micro model31/12/201731/07/201831/08/2018DutchPDF
Micro model31/12/201615/06/201707/07/2017DutchPDF
Abridged model31/12/201516/06/201628/06/2016DutchPDF
Abridged model31/12/201418/06/201515/07/2015DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Philippe Verzele
DirectorManager2018 accountsended
Vanessa Pluym
DirectorManager2018 accountsended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates24/01/2024
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - DOEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Other01/08/2013
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings12 filings
Mandates
Philippe Verzele
Vanessa Pluym
20132014201520162017201820192020202120222023202420252026
Conrad Pharma
Diependale 8, 9700 Oudenaarde
Director
Director
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Diependale 8, 9700 OudenaardeCurrent
accounts 2021 → 2025
Accounts 2025 · 2026-00472409

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
Conrad PharmaCurrent
accounts 2021 → 2025
Accounts 2025 · 2026-00472409

Events

  1. 2025
    Annual accounts 2025199,2 k €↑
  2. 2024
    Annual accounts 2024188,6 k €↓
  3. 2023
    Annual accounts 2023192,3 k €↓
  4. 2022
    Annual accounts 2022295,5 k €↑
  5. 2021
    Annual accounts 2021189,4 k €↑
  6. 2020
    Annual accounts 2020151,8 k €↑
  7. 2019
    Annual accounts 2019146,4 k €↑
  8. 2018
    Annual accounts 201819,8 k €↓
  9. 2017
    Annual accounts 201733 k €↑
  10. 2016
    Annual accounts 2016321,4 €↓
  11. 2015
    Annual accounts 2015959,3 €↑
  12. 2014
    Annual accounts 2014-21,1 k €
  13. 23/07/2013
    IncorporationPrivate limited company